English Aron R.'s Form 4 filing
Anebulo Pharmaceuticals, Inc. (ANEB) · filed Dec 3, 2021
- Accession no.
- 0001493152-21-030384
- Filed
- Dec 3, 2021, 11:16 AM ET
- Trade date
- Dec 2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $73.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| English Aron R.CIK 0001770436 | Director, 10% Owner, Other: See Explanation Response |
| 22NW Fund, LPCIK 0001640809 | Other: See Explanation Response |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +13,836 | $5.30 | +$73,330.8 | 3,357,401 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.